Molecular and Cellular Pathogenesis of Emery-Dreifuss Muscular Dystrophy
Molecular and Cellular Pathogenesis of Emery-Dreifuss Muscular Dystrophy
批准号:
7808357
负责人:
Jason Cheol Choi
金额:
$5.01万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-02-01 至 2013-01-31
关键词:
ActinsAffectAmino AcidsBindingBinding ProteinsBiochemicalBiological AssayBlood CirculationCardiacCardiac MyocytesCardiomyopathiesCell NucleusCellsClinicalCo-ImmunoprecipitationsComplexCytoskeletonDataDefectDevelopmentDigitoninDiseaseEmery-Dreifuss Muscular DystrophyEnergy TransferEnsureFluorescenceFluorescence MicroscopyFluorescence Recovery After PhotobleachingFluorescence Resonance Energy TransferGenesGoalsGrowth FactorHeartHereditary DiseaseHumanIn VitroInflammatoryIntegral Membrane ProteinIntermediate FilamentsKnock-in MouseKnowledgeLamin Type ALeadLifeLinkMAPK1 geneMAPK8 geneMaintenanceMeasuresMediatingMembrane ProteinsMethodsMitogen-Activated Protein KinasesMitogensMolecularMutationMyocardiumN-terminalNuclear EnvelopeNuclear ImportNuclear Inner MembraneNuclear LaminaNuclear StructureNuclear TranslocationPathogenesisPathway interactionsPatientsPhotobleachingPoint MutationProtein Kinase InteractionProteinsScapuloilioperoneal Atrophy with CardiopathySignal PathwaySkeletal MuscleSmall Interfering RNAStimulusStressSurfaceSymptomsTechniquesTestingTherapeutic InterventionTimeTissuesYeastsbasebiological adaptation to stresscytokineeffective therapyextracellularmouse modelmuscular dystrophy mouse modelmutantoverexpressionpreventreconstitutionresearch studyresponsetreatment strategyyeast two hybrid system
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The overall goal of this application is to define the molecular pathogenesis of cardiomyopathy associated with Emery-Dreifuss Muscular Dystrophy (EDMD). Autosomal dominant EDMD arises from mutations in a gene encoding A-type lamins, which are intermediate filaments involved in the maintenance of nuclear structure. Further, A-type lamins (along with suns and nesprins) are a component of the LINC complex, which establish a physical connection between the nucleus and the actin cytoskeleton. In EDMD mouse models of EDMD, mitogen activated protein (MAP) kinases ERK and JNK are activated in the heart tissue prior to the development of cardiomyopathy. As MAP kinase activation is well established to be linked to cardiomyopathy, determining how A-type lamin mutations cause activation of MAP kinases will provide key information on the molecular pathogenesis of cardiomyopathy. We hypothesize that EDMD causing mutations lamin A facilitate MAP kinase activation via two distinct mechanisms: 1) mutant lamin A may disrupt the UNC complex, compromising the integrity of the nucleo- cytoskeleton and generating a stress response that activates the MAP kinase pathway and 2) functional disruption of MAP kinase anchors by direct and indirect mechanisms. Lamin A mutations may directly inhibit the function of lamin A as a putative MAP kinase sequestering anchor to facilitate nuclear translocation. Further, mutations in lamin A may disrupt the LINC complex and hence, the function of cytoplasmic anchors that require intact cytoskeleton. To test our hypothesis, we propose two specific aims. Aim 1 will determine whether disrupting the LINC complex in primary cardiomyocytes will activate MAP kinases. We will disrupt the LINC complex by expressing mutant forms of lamin A, suns, and nesprins that prevent interactions necessary to establish the LINC complex and assess for MAP kinase activation by standard biochemical and fluorescence microscopy techniques. Aim 2 will characterize lamin A and MAP kinase interactions in intact cells by various methods and the effect of lamin A mutations on this interaction. We will assess the functional consequence of lamin A mutation on MAP kinase anchors by measuring the mobility of MAP kinases by FRAP and FLIP analysis. Heart muscle damage is the most serious and life-threatening symptom of EDMD. Understanding how defective proteins of the cell nucleus lead to EDMD-associated heart muscle damage will provide the knowledge necessary to devise an effective treatment strategy. This knowledge may also be applicable to similar heart muscle damage resulting from disorders other than EDMD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cell type-specific function of LMNA during myocardial stress in the development of cardiomyopathy
-
批准号:10357670
-
项目类别:
-
资助金额:$39.22万
-
财政年份:2020
-
负责人:Jason Cheol Choi
-
依托单位:
Cell type-specific function of LMNA during myocardial stress in the development of cardiomyopathy
-
批准号:10565904
-
项目类别:
-
资助金额:$39.0万
-
财政年份:2020
-
负责人:Jason Cheol Choi
-
依托单位:
Dusp4 in the pathogenesis of LMNA cardiomyopathy
-
批准号:9207012
-
项目类别:
-
资助金额:$24.56万
-
财政年份:2016
-
负责人:Jason Cheol Choi
-
依托单位:
Dusp4 in the pathogenesis of LMNA cardiomyopathy
-
批准号:8487168
-
项目类别:
-
资助金额:$13.5万
-
财政年份:2013
-
负责人:Jason Cheol Choi
-
依托单位:
Molecular and Cellular Pathogenesis of Emery-Dreifuss Muscular Dystrophy
-
批准号:8215808
-
项目类别:
-
资助金额:$5.57万
-
财政年份:2010
-
负责人:Jason Cheol Choi
-
依托单位:
Molecular and Cellular Pathogenesis of Emery-Dreifuss Muscular Dystrophy
-
批准号:8018139
-
项目类别:
-
资助金额:$5.3万
-
财政年份:2010
-
负责人:Jason Cheol Choi
-
依托单位:
海外基金